ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
21 hedge funds and large institutions have $55.5M invested in Anebulo Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.91% less ownership
Funds ownership: 54.99% → 54.08% (-0.91%)
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$213K | |
| 2 | +$67.1K | |
| 3 | +$57.4K | |
| 4 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
+$47.1K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$45.1K |
Top Sellers
| 1 | -$503K | |
| 2 | -$221K | |
| 3 | -$74.4K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$36K |
| 5 |
Goldman Sachs
New York
|
-$16.7K |